ArticleAmerican journal of ophthalmology case reports2020
Orbital myeloid sarcoma (chloroma): Report of 2 cases and literature review.
Article in American journal of ophthalmology case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 26 citations in OpenAlex.
- Myeloid sarcoma of the sternum with regional lymph node involvement in a 6-year-old child: a case report.Journal of cardiothoracic surgery · 2026Article
- Extramedullary Relapse ofInternational journal of molecular sciences · 2025Article
- Article
- Isolated orbital granulocytic sarcoma.Eye (London, England) · 2025Article
- Orbital Myeloid Sarcoma: An Initial Presentation of Acute Myeloid Leukemia With Maturation.Cureus · 2025Article
- Pediatric orbital lesions: neoplastic extraocular soft-tissue lesions.Pediatric radiology · 2024Article
- Case report: Orbital myeloid sarcoma: a report of two rare cases and review of the literature.Pathology oncology research : POR · 2024Review
- Regression of a Myeloid Sarcoma of the Nasal Cavity With Extension to the Cheek After Radiotherapy.Cureus · 2023Article
- Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report.BMC ophthalmology · 2022Article
- Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives.Clinical ophthalmology (Auckland, N.Z.) · 2022Review
- Orbital myeloid sarcoma misdiagnosed for subperiostal hematoma: a case report.Journal of medical case reports · 2021Article
- Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma - A Case Report.International medical case reports journal · 2021Article
- Hemophagocytic lymphohistiocytosis of the ocular adnexal mimicking orbital cellulitis in a patient with unknown X-linked lymphoproliferative syndrome type 1 (XLP1): Case report and literature review.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
- Acute unilateral proptosis in childhood: suspect myeloid sarcoma.Romanian journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMyeloid sarcoma (MS) of the orbit is an uncommon condition in occurring in children, generally coupled to myeloproliferative neoplasms. OBSERVATIONS: We describe two rare cases of orbital MS in young boys with aggressive local symptoms but without evidence of acute myeloid leukemia (AML), both patients underwent orbitotomy for gross-tumor resection and biopsy. At follow up, there was no evidence of recurrence nor evolution of the myeloproliferative neoplasms clinically and by radiological and laboratory work-up. We also provide a detailed description of the magnetic resonance imaging presentation, with an extensive pathological analysis correlation. CONCLUSIONS AND IMPORTANCE: A comprehensive revision of the literature on isolated orbital MS was carried out with particular emphasis on clues for differential diagnosis and treatment options, stressing the need to consider MS even in the absence of sign and symptoms of an underlying myeloproliferative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.